Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (10) , 1235-1242
- https://doi.org/10.1038/modpathol.3800171
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive ComponentsThe American Journal of Surgical Pathology, 2003
- Nuclear Accumulation of p53 Is a Potential Marker for the Development of Squamous Cell Lung Cancer in SmokersChest, 2003
- Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor PrognosisAnnals of Surgical Oncology, 2001
- Nuclear p53 accumulation by small‐sized adenocarcinomas of the lungPathology International, 1996
- Survival in early-stage non-small cell lung cancerThe Annals of Thoracic Surgery, 1995
- p53 in Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- p53 Mutations in Human CancersScience, 1991